P55PIK-PI3K stimulates angiogenesis in colorectal cancer cell by activating NF-κB pathway

Angiogenesis

Volumn 16, Issue 3, 2013, Pages 561-573

  Wang, Guihua ^a   Chen, Cheng ^a   Yang, Rui ^a   Cao, Xiaonian ^a   Lai, Senyan ^a   Luo, Xuelai ^a   Feng, Yongdong ^a   Xia, Xianmin ^a   Gong, Jianping ^a   Hu, Junbo ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Angiogenesis; Colorectal cancer; NF B; p55PIK

Indexed keywords

CD31 ANTIGEN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE REGULATORY SUBUNIT 3 GAMMA; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CELL MIGRATION; CELL PROLIFERATION; COLORECTAL CANCER; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TUMOR VASCULARIZATION; UPREGULATION;

BLOTTING, WESTERN; CELL LINE, TUMOR; COLORECTAL NEOPLASMS; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MICROARRAY ANALYSIS; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PHOSPHATIDYLINOSITOL 3-KINASES; REAL-TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84879232002     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-013-9336-y     Document Type: Article

References (50)

1. Anderson DH (2010) p85 Plays a critical role in controlling flux through the PI3K/PTEN signaling axis through dual regulation of both p110 (PI3K) and PTEN. Cell Cycle 9:2055-2056
2. Berenjeno IM, Vanhaesebroeck B (2009) PI3K regulatory subunits lose control in cancer. Cancer Cell 16:449-450
3. Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3:401-410
4. Bikfalvi A (2006) Angiogenesis: health and disease. Ann Oncol 17(Suppl 10):x65-x70
5. Bunney TD, Katan M (2010) Phosphoinositide signalling in cancer: beyond PI3K and PTEN. Nat Rev Cancer 10:342-352
6. Carmeliet P (2003) Angiogenesis in health and disease. Nat Med 9:653-660
7. Cook KM, Figg WD (2010) Angiogenesis inhibitors: current strategies and future prospects. CA Cancer J Clin 60:222-243
8. Courtney KD, Corcoran RB, Engelman JA (2010) The PI3K pathway as drug target in human cancer. J Clin Oncol 28:1075-1083
9. Dayan F, Bilton RL, Laferriere J, et al. (2009) Activation of HIF-1alpha in exponentially growing cells via hypoxic stimulation is independent of the Akt/mTOR pathway. J Cell Physiol 218:167-174
10. Du J, Xu R, Hu Z, et al. (2011) PI3K and ERK-induced Rac1 activation mediates hypoxia-induced HIF-1alpha expression in MCF-7 breast cancer cells. PLoS One 6:e25213
11. Ellis LM, Hicklin DJ (2008) VEGF-targeted therapy: mechanisms of anti-tumour activity. Nat Rev Cancer 8:579-591
12. Eltzschig HK, Carmeliet P (2011) Hypoxia and inflammation. N Engl J Med 364:656-665
13. Fang J, Ding M, Yang L, et al. (2007) PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis. Cell Signal 19:2487-2497
14. Foukas LC, Berenjeno IM, Gray A, et al. (2010) Activity of any class IA PI3K isoform can sustain cell proliferation and survival. Proc Natl Acad Sci U S A 107:11381-11386
15. Grothey A, Galanis E (2009) Targeting angiogenesis: progress with anti-VEGF treatment with large molecules. Nat Rev Clin Oncol 6:507-518
16. Hamada K, Sasaki T, Koni PA, et al. (2005) The PTEN/PI3K pathway governs normal vascular development and tumor angiogenesis. Genes Dev 19:2054-2065
17. Hicklin DJ, Ellis LM (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23:1011-1027
18. Hu J, Liu S, Wang J, et al. (2005) Overexpression of the N-terminal end of the p55gamma regulatory subunit of phosphatidylinositol 3-kinase blocks cell cycle progression in gastric carcinoma cells. Int J Oncol 26:1321-1327
19. Hu J, Xia X, Cheng A, et al. (2008) A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy. Mol Cancer Ther 7:3719-3728
20. Hubbard J, Grothey A (2010) Antiangiogenesis agents in colorectal cancer. Curr Opin Oncol 22:374-380
21. Jia S, Liu Z, Zhang S, et al. (2008) Essential roles of PI(3)K-p110beta in cell growth, metabolism and tumorigenesis. Nature 454:776-779
22. Jiang BH, Liu LZ (2009) PI3K/PTEN signaling in angiogenesis and tumorigenesis. Adv Cancer Res 102:19-65
23. Karar J, Maity A (2011) PI3K/AKT/mTOR Pathway in Angiogenesis. Front Mol Neurosci 4:51
24. Kerbel RS (2008) Tumor angiogenesis. N Engl J Med 358:2039-2049
25. Kloo B, Nagel D, Pfeifer M, et al. (2011) Critical role of PI3K signaling for NF-kappaB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells. Proc Natl Acad Sci U S A 108:272-277
26. Lawrence T, Bebien M, Liu GY, et al. (2005) IKKalpha limits macrophage NF-kappaB activation and contributes to the resolution of inflammation. Nature 434:1138-1143
27. Marone R, Cmiljanovic V, Giese B, et al. (2008) Targeting phosphoinositide 3-kinase: moving towards therapy. Biochim Biophys Acta 1784:159-185
28. Maxwell PH, Dachs GU, Gleadle JM, et al. (1997) Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci U S A 94:8104-8109
29. Menakuru SR, Brown NJ, Staton CA, et al. (2008) Angiogenesis in pre-malignant conditions. Br J Cancer 99:1961-1966
30. Mitchell DC, Bryan BA (2010) Anti-angiogenic therapy: adapting strategies to overcome resistant tumors. J Cell Biochem 111:543-553
31. Mylonis I, Chachami G, Paraskeva E, et al. (2008) Atypical CRM1-dependent nuclear export signal mediates regulation of hypoxia-inducible factor-1alpha by MAPK. J Biol Chem 283:27620-27627
32. Okumura N, Yoshida H, Kitagishi Y, et al. (2012) PI3K/AKT/PTEN signaling as a molecular target in leukemia angiogenesis. Adv Hematol 2012:843085
33. Pufe T, Lemke A, Kurz B, et al. (2004) Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor. Am J Pathol 164:185-192
34. Rhodes DR, Yu J, Shanker K, et al. (2004) Large-scale meta-analysis of cancer microarray data identifies common transcriptional profiles of neoplastic transformation and progression. Proc Natl Acad Sci U S A 101:9309-9314
35. Rhodes DR, Yu J, Shanker K, et al. (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6:1-6
36. Sakurai H, Chiba H, Miyoshi H, et al. (1999) IkappaB kinases phosphorylate NF-kappaB p65 subunit on serine 536 in the transactivation domain. J Biol Chem 274:30353-30356
37. Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C (T) method. Nat Protoc 3:1101-1108
38. Skrzypczak M, Goryca K, Rubel T, et al. (2010) Modeling oncogenic signaling in colon tumors by multidirectional analyses of microarray data directed for maximization of analytical reliability. Plos One 5:e13091
39. Tian T, Nan KJ, Wang SH, et al. (2010) PTEN regulates angiogenesis and VEGF expression through phosphatase-dependent and -independent mechanisms in HepG2 cells. Carcinogenesis 31:1211-1219
40. Tsuzuki Y, Fukumura D, Oosthuyse B, et al. (2000) Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1alpha-> hypoxia response element-> VEGF cascade differentially regulates vascular response and growth rate in tumors. Cancer Res 60:6248-6252
41. Van Uden P, Kenneth NS, Rocha S (2008) Regulation of hypoxia-inducible factor-1alpha by NF-kappaB. Biochem J 412:477-484
42. Vanhaesebroeck B, Guillermet-Guibert J, Graupera M, et al. (2010) The emerging mechanisms of isoform-specific PI3K signalling. Nat Rev Mol Cell Bio 11:329-341
43. Wang G, Deng Y, Cao X, et al. (2012) Blocking p55PIK Signaling inhibits proliferation and induces differentiation of leukemia cells. Cell Death Differ 19:1870-1879
44. Wee S, Wiederschain D, Maira SM, et al. (2008) PTEN-deficient cancers depend on PIK3CB. Proc Natl Acad Sci U S A 105:13057-13062
45. Weidner N, Semple JP, Welch WR, et al. (1991) Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 324:1-8
46. Winder T, Lenz HJ (2010) Vascular endothelial growth factor and epidermal growth factor signaling pathways as therapeutic targets for colorectal cancer. Gastroenterology 138:2163-2176
47. Xia X, Cheng A, Akinmade D, et al. (2003) The N-terminal 24 amino acids of the p55 gamma regulatory subunit of phosphoinositide 3-kinase binds Rb and induces cell cycle arrest. Mol Cell Biol 23:1717-1725
48. Yuan TL, Cantley LC (2008) PI3K pathway alterations in cancer: variations on a theme. Oncogene 27:5497-5510
49. Zhang L, Huang J, Yang N, et al. (2007) Integrative genomic analysis of phosphatidylinositol 3′-kinase family identifies PIK3R3 as a potential therapeutic target in epithelial ovarian cancer. Clin Cancer Res 13:5314-5321
50. Zhao L, Vogt PK (2008) Class I PI3K in oncogenic cellular transformation. Oncogene 27:5486-5496